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Abstract Background: Osteoporotic hip fractures typical-
ly occur in frail elderly patients with multiple comorbidities,
and repair of the fracture within 48 h is recommended. Pre-
operative evaluation sometimes involves transthoracic echo-
cardiography (TTE) to screen for heart disease that would
alter peri-operative management, yet TTE can delay surgery
and is resource intensive. Evidence suggests that the use of
clinical practice guidelines (CPGs) can improve care. It is
unclear which guidelines are most useful in hip fracture
patients. Questions/Purposes: We sought to evaluate the
performance of the five commonly used CPGs in determin-
ing which patients with acute fragility hip fracture require
TTE and to identify common features among high-
performing CPGs that could be incorporated into care path-
ways. Patients and Methods: We performed a retrospective
study of medical records taken from an institutional database
of osteoporotic hip fracture patients to identify those who
underwent pre-operative TTE. History and physical exami-
nation findings were recorded; listed indications for TTE
were compared against those given in five commonly used
CPGs: those from the American College of Cardiology/
American Heart Association (ACC/AHA), the British Soci-
ety of Echocardiography (BSE), the European Society of
Cardiology and the European Society of Anaesthesiology(ESC/
ESA), the Association of Anaesthetists of Great Britain and
Ireland (AAGBI), and the Scottish Intercollegiate Guidelines
Network (SIGN). We then calculated the performance (sensi-
tivity and specificity) of the CPGs in identifying patients with
TTE results that had the potential to change peri-operative
management. Results: We identified 100 patients who
underwent pre-operative TTE. Among those, the patients met
criteria for TTE 32 to 66% of the time, depending on the CPG
used. In 14% of those receiving TTE, the test revealed new
information with the potential to change management. The
sensitivity of the CPGs ranged from 71% (ESC/ESA and
AAGBI) to 100% (ACC/AHA and SIGN). The CPGs’
specificity ranged from 37% (BSE) to 74% (ESC/ESA).
The more sensitive guidelines focused on a change in
clinical status in patients with known disease or clinical
concern regarding new-onset disease. Conclusions: In pa-
tients requiring fixation of osteoporotic hip fractures, TTE
can be useful for identifying pathologies that could direct-
ly change peri-operative management. Our data suggest
that established CPGs can be safely used to identify which
patients should undergo pre-operative TTE with low risk
of missed pathology.
Keywords clinical practice guidelines.echocardiogram.
pre-operative clearance .peri-operative management
Introduction
Osteoporotic fragility fracture of the hip is common and
places significant clinical and financial burdens on the
healthcare system [10, 11]. It typically occurs in elderly
patients, many of whom are medically frail [17, 28] and
have chronic medical issues that may not be controlled at
the time of fracture [7, 17, 27, 28]. Because of these medical
complexities, several clinical practice guidelines (CPGs)
have been developed that make recommendations on the
optimal management of such cases [1, 4, 5, 14, 15, 22].
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The process of best preparing these medically complex
patients for surgery is challenging. Typically, guidelines
recommend rapid evaluation and surgical fixation of the
fracture—within 24 to 48 h—with pre-operative workup
and treatment limited only to things likely to directly affect
peri-operative management [18, 20, 21, 23, 24, 26]. One
evaluation that may delay surgical fixation, however, is
transthoracic echocardiography (TTE) [6, 12, 16], which is
used to assess for possibly treatment-limiting heart disease;
requires a dedicated technician, not to mention the necessary
equipment; and is not typically performed outside of day-
time hospital hours [3, 13, 19, 25].
Studies have shown CPGs to be useful in determining who
should undergo TTE [2, 8, 9], although criteria to determine
who should receive TTE have not been firmly established, and
several different CPGs have been proposed. Broadly, they
tend to focus on the known or suspected presence of valvular
disease, heart failure, or pulmonary hypertension, but they
differ slightly in terms of criteria for screening with TTE.
Some of these CPGs were specifically written with hip frac-
ture patients in mind, whereas others were designed for use
before elective, planned surgery. However, their accuracy in
identifying which patients are likely to have pathology that
necessitates TTE is not well established.
The purposes of this study were to evaluate the perfor-
mance of five commonly used CPGs in determining which
patients with acute fragility hip fractures should undergo
TTE and to identify common features among high-
performing CPGs that could be incorporated into care
pathways.
Methods
This was a retrospective cohort study of patients with oste-
oporotic hip fractures who underwent TTE as part of their
pre-operative “clearance” evaluation. Patients were identi-
fied from a prospectively maintained database of hip fracture
patients older than 55 years that included a record of who
underwent TTE during hospitalization.
We received approval from the institutional review board
at Atrium Health Musculoskeletal Institute in Charlotte, NC,
USA, where the patients were treated. Study data were
retrieved through a review of patient charts. Data extracted
included pre-operative demographics and medical character-
istics, including age, sex, comorbidities and medical history,
and critical physical examination findings as documented in
consultation notes from the medical and orthopedic teams.
We also reviewed indications for TTE listed in the order,
when available.
We then reviewed the patients’ medical histories and
physical examination findings against the indications for
TTE as specified in five commonly used CPGs: those from
the American College of Cardiology/American Heart Asso-
ciation (ACC/AHA) [14], the British Society of Echocardi-
ography (BSE) [5], the European Society of Cardiology and
the European Society of Anaesthesiology (ESC/ESA) [15],
the Association of Anaesthetists of Great Britain and Ireland
(AAGBI) [1], and the Scottish Intercollegiate Guidelines
Network (SIGN) [22] (Table 1).
We then reviewed the individual TTE reports for the
presence of pathologies likely to change peri-operative med-
ical management. The TTE reports for each patient were
reviewed by a research team member blinded to CPG ad-
herence. Indications for changes in management included a
diminished left ventricular ejection fraction (below 25%);
pulmonary hypertension, as indicated by an elevated right
ventricular systolic pressure (greater than 55 mmHg); and
the identification of new or worsening valvular disease
classified as “moderate” or “severe” [6, 12]. Typical changes
to management included the choice of anesthetic agent (e.-
g., spinal versus general anesthesia), peri-operative monitor-
ing decisions (such as an arterial line or telemetry), and peri-
operative fluid management.
Once we had determined which patients had an indica-
tion for changes to peri-operative management that
included the use of TTE—according to each specific
CPG—and those who underwent TTE that provided infor-
mation that could alter medical management, we were able
to determine the test-performance characteristics. We
Table 1 Indications for TTE, by guideline
Guideline Indications for TTE
ACC/AHA [14] • Dyspnea of unknown origin
• Worsening of known heart failure signs or symptoms
• Known history of valvular dysfunction or heart failure without echocardiography in last year or worsened symptoms
• Suspicion of moderate or greater valvular stenosis or regurgitation
BSE [5] • Documented ischemic heart disease
• Unexplained dyspnea
• Murmur with concomitant cardiac or respiratory symptoms
• Murmur in asymptomatic patient where structural heart disease is suspected
ESC/ESA [15] • Presumed or confirmed severe valvular disease
AAGBI [1] • Dyspnea at rest or low level of exertion
• Murmur suggestive of significant aortic stenosis
SIGN [22] • New murmur that raises concerns about aortic stenosis
• Known murmur in the presence of worsening clinical symptoms
TTE transthoracic echocardiography, ACC/AHA American College of Cardiology/American Heart Association, BSE British Society of Echocar-
diography, ESC/ESA European Society of Cardiology and the European Society of Anaesthesiology, AAGBI Association of Anaesthetists of
Great Britain and Ireland, SIGN Scottish Intercollegiate Guidelines Network
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calculated sensitivity and specificity, comparing the test
result (whether or not TTE was indicated according to a
CPG) with the presence of actual disease found on TTE
(i.e., a finding that could change peri-operative manage-
ment, although we could not assess whether management
did change).
Results
Over a 4-year period, there were 538 patients over the age of
55 years presenting with osteoporotic fragility hip fractures.
Of those, TTE was performed in 121 (22%). Of the patients
in whom TTE was performed, 21 patients underwent it for a
reason other than a finding from pre-operative evaluation
(e.g., as part of a resuscitation code or an acute stroke
evaluation), leaving 100 patients who met study criteria
and were included in our analysis. The mean age at the time
of admission was 82 years (range, 59 to 100 years; standard
deviation, 10.5 years), and 74% of the patients were female.
The most common comorbidities were hypertension (62%),
congestive heart failure (42%), hyperlipidemia (29%), and
diabetes mellitus (27%) (Table 2).
Review of TTE reports showed that information with the
potential to change management was identified in 14 patients
(14%). Pathologies identified included new or worsened valvu-
lar disease (six patients), new or worsened pulmonary
hypertension (five patients), a significant decline in ejection
fraction (one patient), a newly identified left ventricular outflow
tract obstruction (one patient), and a new diagnosis of hyper-
trophic cardiomyopathy (one patient).
The indications or reasons for TTE given in the orders
included clinical concern regarding worsening heart fail-
ure (29%), a new or worsening murmur (25%), no clear
indication (e.g., “pre-operative clearance” or “evaluate LV
function”; 29%), or other cardiac clinical concern (e.-
g., “new-onset atrial fibrillation” or “elevated troponin
levels”; 17%).
When the performance of the CPGs was compared
(Table 3), TTE was conducted in accordance with the re-
spective criteria 32% to 66% of the time. The sensitivity of
the CPGs ranged from 71% (ESC/ESA and AAGBI) to
100% (ACC/AHA and SIGN). The CPGs’ specificity
ranged from 37% (BSE) to 74% (ESC/ESA).
Discussion
The pre-operative management of elderly patients with os-
teoporotic hip fractures is challenging. In the context of
evolving treatment options and evidence, CPGs can provide
expert-reviewed, evidence-based guidelines to help design
treatment pathways for these medically frail patients. The
optimal guidelines would help minimize unnecessary testing
while still identifying patients who could have a significant
pathology that would be seen on TTE and that might change
peri-operative management. In our series, new information
with the potential to directly alter management was found in
14% of 100 patients undergoing TTE, but the indications for
undergoing TTE were not always clear in the first place.
This highlights the importance of having guidelines with
criteria that clearly spell out when to administer resource-
intensive tests such as TTE.
This analysis has several limitations. First, the study is
retrospective, and a well-established protocol for determining
which patients required TTE was not applied in this patient
group. As a result, our findings are heavily dependent on our
institution’s protocol, which may affect generalizability. Also,
the retrospective nature of the study necessitated reliance on
documentation of the medical team findings and the indications
Table 2 Prevalence of comorbidities on presentation
Documented comorbidity on presentation Prevalence
Hypertension 62%




History of cancer 22%
Depression 22%
Chronic obstructive pulmonary disease 21%
Cerebrovascular accident 19%
Gastroesophageal reflux disease 17%
End-stage renal disease 4%
History of previous fragility fracture 4%
Hemodialysis 3%
Table 3 Performance (sensitivity and specificity) of the five CPGs
Guideline
ACC/AHA BSE ESC/ESA AAGBI SIGN
TTEs performed in accordance with guidelines 66% 65% 32% 50% 66%
Sensitivity 100% 79% 71% 71% 100%
Specificity 40% 37% 74% 54% 40%
Reduction in TTEa 34% 35% 68% 50% 34%
Missed pathologyb 0% 12% 3% 4% 0%
CPG clinical practice guideline, ACC/AHA American College of Cardiology/American Heart Association, BSE British Society of Echocardiog-
raphy, ESC/ESA European Society of Cardiology/European Society of Anaesthesiology, AAGBI Association of Anaesthetists of Great Britain and
Ireland, SIGN Scottish Intercollegiate Guidelines Network, TTE transthoracic echocardiography
a Potential percentage reduction in TTE ordering if CPGs were followed
b Percentage of patients with pathology detected by TTE that would have been missed if CPGs were followed
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for TTE, which could affect the accuracy of our analysis of the
pre-operative assessment. Similarly, we were only able to
screen the study reports for information that had the potential
to change management, rather than any concrete management
changes that actually occurred. Although this may limit the
specificity of the results, we believe this study provides valuable
data supporting the argument that TTE performed outside of
standard CPG recommendations rarely provides new informa-
tion that alters peri-operative management decisions.
This analysis shows that these CPGs (some of which
were initially developed for elective surgery) have different
levels of performance when applied to the pre-operative
evaluation of patients with osteoporotic hip fracture. The
guidelines had sensitivities ranging from 71 to 100%, with
specificities ranging from 37 to 74%. If incorporated into
practice, the highest-performing CPGs (ACC/AHA, ESC/
ESA, and SIGN) could translate into a 30 to 60% reduction
in TTE use, while keeping the rate of missed pathology to
3% or lower, depending on the guideline chosen. In this
patient cohort, the most sensitive guidelines tended to focus
on a change in clinical status in patients with known disease
or clinical concern regarding new-onset disease of at least
moderate severity, reinforcing the importance of accurate
history taking and physical examination when screening
patients pre-operatively.
In conclusion, our study demonstrates that established
CPGs have variable performance when it comes to deter-
mining a need for echocardiography in patients with osteo-
porotic hip fractures. CPGs that focus on worsening
symptoms or clinical examination findings that raise con-
cerns regarding moderate or severe disease (ACC/AHA,
SIGN) had the highest sensitivity and may be the most
suitable for use in screening. Our hope is that thoughtful
application of established guidelines to determine the need
for TTE can minimize unnecessary delays in surgery and
lessen associated resource use while still identifying patients
at risk.
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